本页面由Tiger Trade Technology Pte. Ltd.提供服务

Jupiter Neurosciences

3.04
+0.19006.67%
盘前:2.77-0.2706-8.90%04:14 EDT
成交量:3.72万
成交额:10.73万
市值:400.82万
市盈率:-0.16
高:3.04
开:2.89
低:2.76
收:2.85
52周最高:135.75
52周最低:2.25
股本:131.85万
流通股本:109.87万
量比:0.18
换手率:3.39%
股息:- -
股息率:- -
每股收益(TTM):-18.5676
每股收益(LYR):-18.7500
净资产收益率:-1888.70%
总资产收益率:-159.56%
市净率:-10.95
市盈率(LYR):-0.16

数据加载中...

公司资料

公司名字:
Jupiter Neurosciences
交易所:
NASDAQ
成立时间:
2016
员工人数:
- -
公司地址:
1001 North US Highway 1,Suite 504,Palm Beach Gardens,Jupiter,Florida,United States
邮编:
33477
电话:
传真:
- -
简介:
Jupiter Neurosciences, Inc.于2016年1月在特拉华州注册成立。该公司是一家临床阶段的研究与开发公司,专注于利用其专有的白藜芦醇制剂JOTROL开发针对神经炎症的治疗方法。其主要治疗目标是帕金森病,计划进行IIa期临床试验,并推出了面向消费者的Nugevia产品线,专注于长寿与健康领域。

董事

名称
职位
Christer Rosén
Chairman of the Board and Chief Executive Officer
Alison D. Silva
Chief Operating Officer and Director and President
Holger Weis
Independent Director
Nicholas H. Hemmerly
Independent Director

股东

名称
职位
Christer Rosén
Chairman of the Board and Chief Executive Officer
Alison D. Silva
Chief Operating Officer and Director and President
Saleem Elmasri
Chief Financial Officer and Secretary
Alexander Rosén
Chief Administrative Officer
Marshall Hayward
Chief Scientific Officer